中信建投-卫光生物(002880)Plasma collection volume maintains steady growth,actively advancing innovative R&D-260518

登录忘记密码注册

>> 中信建投-卫光生物(002880)Plasma collection volume maintains steady growth,actively advancing innovative R&D-260518

上传日期：	2026/5/18	大小：	461KB
格式：	pdf 共8页	来源：	中信建投
评级：	--	作者：	--
下载权限：	此报告为加密报告

相关研报

中信建投-通信：Large models soar,and the computing power boom is moving deeper-260518
中信建投-巴比食品(605338)Cost dividend continues,seize the acceleration period of new store formats-260518
中信建投-浙江龙盛(600352)Cyclical recovery materializing,the dye industry leader poised to regain pricing power-260515
中信建投-京东工业(07618.HK)1Q26 results review：Performance beat expectations,increased shareholder returns-260515
中信建投-斯菱智驱(301550)Results broadly in line;new businesses gaining momentum;global expansion accelerating-260515
中信建投-百奥赛图(688796)Dual-driven by model animals and antibody licensing,with profit elasticity continuously released-260514
中信建投-阿里巴巴-W(09988.HK)FY2026Q4 earnings review_Resonance between cloud and core businesses,full-stack AI begins to show results-260514
中信建投-京东健康(06618.HK)1Q26 results review_Results slightly beat expectations,shareholder returns boost market confidence-260514
中信建投-有色金属：Synergy of technology development and scarcity_Strategic metals and new materials embrace strong growth-260514
中信建投-CSI SOLAR(688472)Strong energy storage system shipments support earnings; buyback program demonstrates business confidence-260514

Copyright © 2005 - 2021 Nxny.com All Rights Reserved 备案号：蜀ICP备15031742号-1